In the TACTICS-HF trial, how many patients on average needed to be treated with tolvaptan to cause one case of renal dysfunction?

In the TACTICS-HF trial, how many patients on average needed to be treated with tolvaptan to cause one case of renal dysfunction?

• A. 1.
• B. 9.
• C. 11.
• D. 14.

Answer: (C)

In the TACTICS-HF trial, tolvaptan's effectiveness and safety profile were assessed, particularly in patients with acute heart failure. The findings indicated that multiple patients experienced renal dysfunction as a side effect of tolvaptan treatment. The number needed to treat (NNT) to observe one instance of renal dysfunction was identified as 11. This means that for every 11 patients treated with tolvaptan, one patient was expected to develop renal dysfunction as a consequence of the medication.

Understanding NNT is crucial in clinical practice, as it helps healthcare providers weigh the benefits of a treatment against its risks. In this case, while tolvaptan may provide certain benefits in managing fluid retention in heart failure, the associated risk of renal dysfunction is significant enough to inform treatment decisions. Thus, recognizing that approximately 11 patients need to be treated to see one adverse renal outcome is important for patient safety and effective medication management in the context of heart failure treatment.